Keyphrases
Bisphenol A
100%
Mass Spectrometry Imaging
100%
Glycerophospholipids
100%
Mouse Liver
100%
Fatty Acid Remodeling
100%
Lipidome
30%
Liver Sections
30%
Lysophosphatidylethanolamine
30%
Lysophosphatidylserine
30%
Spatial Distribution
20%
Metabolism
20%
Liver
20%
Phosphatidylethanolamine
20%
Liver Tissue
20%
Lysophosphatidylcholine
20%
Phosphatidylcholine
20%
Acyltransferase
20%
Remodeling Pathways
20%
Fatty Acids
10%
Analytical Results
10%
Lipids
10%
Mouse Model
10%
Multivariate Statistical Analysis
10%
Metabolic Disorders
10%
Toxicity Evaluation
10%
Lipid Analysis
10%
Hepatic Expression
10%
Matrix-assisted Laser Desorption Ionization Mass Spectrometry Imaging
10%
Olive Oil
10%
Lipid Metabolites
10%
Causes of Variation
10%
LPCAT2
10%
Hepatic Disease
10%
Abundance Variation
10%
Structural Lipids
10%
LPCAT3
10%
Lysophosphatidic Acid Acyltransferase (LPAAT)
10%
Phospholipase A2 (PLA2)
10%
Lipid Biomarkers
10%
Lipid Abundance
10%
Biochemistry, Genetics and Molecular Biology
Lipid
100%
Mass Spectrometry Imaging
100%
Glycerophospholipid
100%
Lipidome
60%
Lysophosphatidylcholine
60%
Lysophosphatidylethanolamine
60%
N-Acetyltransferase
60%
Metabolic Pathway
40%
Phosphatidylserine
40%
Phosphatidylethanolamine
40%
Lecithin
40%
Mouse Model
20%
Enzyme
20%
Anabolism
20%
Metabolite
20%
Upregulation
20%
Downregulation
20%
Lipidomics
20%
Matrix-Assisted Laser Desorption/Ionization
20%
Multivariate Analysis
20%
Body Weight
20%
Phospholipase A2
20%
Olive tree
20%
Pharmacology, Toxicology and Pharmaceutical Science
Glycerophospholipid
100%
Fatty Acid
100%
Lipidome
50%
Lysophosphatidylserine
50%
4,4' Isopropylidenediphenol
33%
Phosphatidylserine
33%
Phosphatidylethanolamine
33%
Egg Lecithin
33%
Lysophosphatidylcholine
33%
Acyltransferase
33%
Mouse Model
16%
Matrix-Assisted Laser Desorption/Ionization
16%
Liver Disease
16%
1 Acylglycerophosphocholine Acyltransferase
16%
Phospholipase A2
16%